Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Thiogenesis Therapeutics, Inc.

Clinical trials sponsored by Thiogenesis Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new oral drug help tame leigh syndrome? Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1 Completed 1

New pill hopes to ease rare mitochondrial disease

Disease control Completed

This study tests an oral drug called TTI-0102 in 12 people with MELAS, a rare genetic disorder that causes muscle weakness, strokes, and fatigue. Participants receive either the drug or a placebo for 6 months. Researchers will measure walking ability, fatigue, and quality of life…

Phase 2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC